pharmaceutical manufacturing
The SemaCyte Multiplexing Platform is an expansion of an existing platform that enables new features for drug discovery
| 2 min read
The reagent t-BuSF improves efficiency of sulfoximine, sulfonimidoyl fluoride, and sulfonimidamide synthesis
| 2 min read
A spider venom molecule has met critical benchmarks towards becoming a treatment for heart attack
| 2 min read
New, high-resolution technique for finding potential therapeutic targets on proteins in living cells
| 2 min read
Researchers have identified a new structural class of antibiotics
| 3 min read
New way to make drug repurposing more efficient presented at leading AI conference
| 2 min read
Researcher has worked out how enzymes can be used to more easily form the desired bond between two nitrogen atoms
| 2 min read
Researchers have developed a way of joining up the head and tail of a protein, making it easier to get into cells
| 2 min read
A new AI model can predict where a pharmaceutically active molecule can be chemically modified and how best to do it
| 4 min read
An analysis of FDA and patent records revealed how manufacturers have extended periods of market exclusivity
| 2 min read
